24 TWENTYFOURSEVENBIOPHARMA Issue 1 / March 2025 PROCOS The Drug, Chemical & Associated Technologies Association (DCAT) Week has long been a cornerstone of strategic engagement for PROCOS and the company is now looking towards DCAT Week 2025. For over 30 years, PROCOS has been an active participant in this global business development forum, utilising the platform to foster relationships, expand collaborations and contribute to pivotal discussions within the pharmaceutical industry. As it looks towards DCAT Week 2025, PROCOS is poised to make a significant impact through two key initiatives: the introduction of its cutting-edge R11 production facility and continued sponsorship of the Women’s Networking Breakfast. As a matter of fact, 2025 marks a transformative year for PROCOS with the commissioning of R11 its state-of-the-art production facility. R11 epitomises the company’s commitment to organic growth within the small molecule CDMO sector, addressing increasing demand for low-volume, high-value complex molecules and Clinical Phase I/ II/III materials. Equipped with four multi-purpose lines, the facility boasts approximately 20 reactors ranging from 1,000 to 6,000 litres, four centrifuges and advanced drying capacities. This first part of the expansion, contributing an additional 73 cubic metres of manufacturing capacity, is a testament to its dedication to innovation and operational excellence. Looking ahead, the planned second part of the expansion will further bolster R11’s capabilities, with the installation of 15 reactors, three centrifuges and enhanced drying technologies, ultimately increasing PROCOS’ total production capacity by 25%. By 2026, R11 is set to play a pivotal role in meeting growing global demand, particularly within the US market, while reinforcing its position as a leading API manufacturer. As PROCOS celebrates its 80th anniversary in 2025, DCAT Week provides the perfect platform to reflect on the company’s journey and envision the future. Since its foundation in 1945, and particularly following integration into the CBC Group in 2006, PROCOS has consistently achieved sustainable growth. The launch of R11 not only enhances production capabilities, but also exemplifies a dedication to meeting evolving client needs through cutting-edge technology and capacity expansion.
RkJQdWJsaXNoZXIy MjY2OTA4MA==